Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Cost-effectiveness of losartan in diabetic nephropathy: a Greek perspective.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cost-effectiveness of losartan in diabetic nephropathy: a Greek perspective.
Cost-effectiveness of losartan in diabetic nephropathy: a Greek perspective. J Nephrol. 2007 Nov-Dec; 20(6):703-15.
View in:
PubMed
subject areas
Angiotensin II Type 1 Receptor Blockers
Cost-Benefit Analysis
Diabetic Nephropathies
Greece
Humans
Kidney Failure, Chronic
Losartan
National Health Programs
authors with profiles
George Bakris